692 results
Page 12 of 35
6-K
EX-99.1
3qqa7dc
26 Oct 12
Teva Receives Approval for Synribotm(omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
0n3rh7s
25 Oct 12
Live Filing
12:00am
6-K
EX-99.1
2gg g612dth2xfb
25 Oct 12
Live Filing
12:00am
6-K
EX-99.1
xf6dov
22 Oct 12
PHASE IIa LAQUINIMOD TRIAL RESULTS SHOW POSITIVE DATA FOR POTENTIAL USE IN ACTIVE CROHN’S DISEASE
12:00am
6-K
EX-99.1
an2037
18 Oct 12
Teva Women’s Health, Inc. to Present New Data at the 68th Annual Meeting of the American Society for Reproductive Medicine
12:00am
6-K
EX-99.1
vmiidw0n0 ecpm0au
10 Oct 12
Teva to Present Positive Data for Glatiramer Acetate 40 MG/1 ML Given Three Times Weekly for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
qtyve
10 Oct 12
New Data Presented at the 28TH Ectrims Congress Showcase Teva’s Ongoing Commitment to Multiple Sclerosis Research
12:00am
6-K
EX-99.1
8v8ik
27 Sep 12
Drug candidate to be assessed for managing voluntary motor disturbances in Huntington disease
12:00am
6-K
EX-99.1
txcwi5 ljz1m3b4bjzdf
17 Sep 12
Bayer HealthCare to acquire U.S. animal health business from Teva Pharmaceutical Industries
12:00am
6-K
EX-99.99
vo37btdpk3fa hhoe
13 Sep 12
Live Filing
12:00am
6-K
EX-99.1
l4e2fw4nia
30 Aug 12
Teva Announces Fda Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-induced Neutropenia
12:00am
6-K
EX-99.1
bi10ar4tv7c1s7ay04
17 Aug 12
Teva Announces Launch of Generic Actos® in the United States
12:00am
6-K
EX-99.1
p4xzdrp0a ut
17 Aug 12
Teva Announces Launch of Generic ACTOplusmet® in the United States
12:00am
6-K
r2nad96
8 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
s6aqtbed
8 Aug 12
Teva to Initiate Third Phase Iii Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
51mh2alp408 iobbdrho
6 Aug 12
Teva Reports Second Quarter 2012 Results
12:00am
6-K
pcey1dvync 5kn908t
2 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
8goo560lp49fyr0ada3s
2 Jul 12
Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia In Breast Cancer Patients Undergoing Chemotherapy
12:00am
6-K
EX-99.1
j3f k7wgl1dtz
21 Jun 12
Teva Announces Launch of Generic Symbyax® in the United States
12:00am
6-K
EX-99.1
viekgeaz7
19 Jun 12
Live Filing
12:00am